Selective antagonism of endothelin ET(A) or ET(B) receptor in renal hemodynamics and function of deoxycorticosterone acetate-salt-induced hypertensive rats

Biological and Pharmaceutical Bulletin

Volumn 22, Issue 8, 1999, Pages 858-862

  Matsumura, Yasuo ^a   Taira, Shima ^a   Kitano, Rika ^a   Hashimoto, Norio ^a   Kuro, Toshihiko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Deoxycorticosterone acetate salt hypertension; Endothelin receptor; Endothelin 1; ET(A) antagonist; ET(B) antagonist; Renal function

Indexed keywords

4 (1,3 BENZODIOXOL 5 YL) 1 [(2,6 DIETHYLPHENYL)CARBAMOYLMETHYL] 2 (4 PROPOXYPHENYL) 3 PYRROLIDINECARBOXYLIC ACID; ATRASENTAN; CREATININE; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTEIN URINE LEVEL; RAT; RECEPTOR BLOCKING; UREA NITROGEN BLOOD LEVEL;

EID: 0032859373     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.22.858     Document Type: Article

References (27)

1. Lariviére R., Thibalt G., Schiffrin E. L., Hypertension, 21, 294-300 (1993).
2. Lariviére R., Day R., Schiffrin E. L., Hypertension, 21, 916-920 (1993).
3. Fujita K., Matsumura Y., Miyazaki Y., Hashimoto N., Takaoka M., Morimoto S., Life Sci., 58, PL1-7 (1996).
4. Fujita K., Matsumura Y., Kita S., Miyazaki Y., Hisaki K., Takaoka M., Morimoto S., Br. J. Pharmacol., 114, 925-930 (1995).
5. Li J. S., Turgeon A., Schiffrin E. L., Am. J. Hypertens., 11, 554-562 (1998).
6. Schiffrin E. L., Sventek P., Li J. S., Turgeon A., Reudelhuber T., Br. J. Pharmacol., 115, 1377-1381 (1995).
7. Li J. S., Lariviére R., Schiffrin E. L., Hypertension, 24, 183-188 (1994).
8. Matsumura Y., Hashimoto N., Fujita K., Morimoto S., Eur. J. Pharmacol., 319, 65-69 (1997).
9. Hashimoto N., Kuro T., Fujita K., Azuma S., Matsumura Y., Biol. Pharm. Bull., 21, 800-804 (1998).
10. Clozel M., Gray G. A., Breu V., Löffler B., Osterwalder R., Biochem. Biophys. Res. Commun., 175, 556-561(1992).
11. Yamashita Y., Yukimura T., Miura K., Okumura M., Yamamoto K., J. Pharmacol. Exp. Ther., 259, 1256-1260 (1991).
12. Yukimura T., Yamashita Y., Miura K., Kim S., Iwao H., Takai M., Okada T., Eur. J. Pharmacol., 264, 399-405 (1994).
13. Opgenorth T. J., Adler A. L., Calzadilla S. V., Chiou W. J., Dayton B.D., Dixon D. B., Gehrke L. J., Hernandez L., Magnuson S. R., Marsh K. C., Novosad E. I., von Geldern T. W., Wessale J. L., Winn M., Wu-Wong J. R., J. Pharmacol. Exp. Ther., 276, 473-481 (1996).
14. Matsumura Y., Hashimoto N., Taira S., Kuro T., Kitano R., Ohkita M., Opgenorth T. J., Takaoka M., Hypertension, 33, 759-765 (1999).
15. Opgenorth T. J., Adler A. L., Wu-Wong J. R., Chiou W. J., Dixon D. B., Wessale J. L., Novosad E. I., Calzadilla S. V., Dayton B. D., Gehrke L. J., Marsh K. C., Nguyen B., Tasker A. S., Sorensen B. K., von Geldern T. W., Abstracts of Papers, 5th International Conference on Endothelin, 1997, O21.
16. Vurek G. G., Pegram S. E., Anal. Biochem., 16, 409-419 (1966).
17. Fujita K., Matsumura Y., Miyazaki Y., Takaoka M., Morimoto S., Jpn. J. Pharmacol., 70, 313-319 (1996).
18. Clozel M., Breu V., FEBS Lett., 383, 42-45 (1996).
19. Mino N., Kobayashi M., Nakajima A., Amano H., Shimamoto K., Ishikawa K., Watanabe K., Nishikibe M., Yano M., Ikemoto F., Eur. J. Pharmacol., 221, 77-83 (1992).
20. Chan L., Chittinandana A., Shapiro J. I., Shanley P. F., Schrier R. W., Am. J. Physiol., 266, F135-F138 (1994).
21. Gellai M., Jugus M., Fletcher T., DeWolf R., Nambi P., J. Clin. Invest., 93, 900-906 (1994).
22. Shimizu T., Kuroda T., Ikeda M., Hata S., Fujimoto M., J. Pharmacol. Exp. Ther., 286, 977-983 (1998).
23. Benigni A., Zoja C., Corna D., Orisio S., Longaretti L., Bertani T., Remuzzi G., Kidney Int., 44, 440-444 (1993).
24. Kohan D. E., Clin. Exp. Pharmacol. Physiol., 23, 337-344 (1996).
25. Gellai M., DeWolf R., Pullen M., Nambi P., Kidney Int., 46, 1287-1294 (1994).
26. Kassab S., Miller T., Novak J., Reckelhoff J., Clower B., Granger J. P., Hypertension, 31[pt2], 397-402 (1998).
27. Orth S. R., Esslinger J. P., Amann K., Schwarz U., Raschack M., Ritz E., Hypertension, 31, 995-1001 (1998).